Stay updated on Ixekizumab for Bullous Pemphigoid Clinical Trial

Sign up to get notified when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixekizumab for Bullous Pemphigoid Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The site footer now identifies the platform revision as v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-03T02:28:38.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The record for a study of ixekizumab in bullous pemphigoid has been replaced by a 403 Forbidden error, leaving the study details unavailable. An NIH transition notice also appears at the top of the page.
    Difference
    20%
    Check dated 2026-10-27T02:34:08.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The study record for the ixekizumab bullous pemphigoid trial is no longer displayed, and the page shows a 403 Forbidden message with a Home link.
    Difference
    19%
    Check dated 2026-10-20T05:18:35.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the Ixekizumab bullous pemphigoid study is now displayed, with study details, participation criteria, treatment plan, outcome measures, and related documents and links.
    Difference
    53%
    Check dated 2026-10-13T07:50:51.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    A new revision tag (v3.7.0) has been added to the page, signaling an update to the study record's version. This reflects a metadata update rather than changes to the study details.
    Difference
    19%
    Check dated 2026-09-22T02:47:32.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page revision number was updated from v3.6.5 to v3.6.6, indicating a minor update to the page’s version. This update appears to be a non-substantive administrative change rather than a modification to study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-08-31T23:08:18.000Z thumbnail image

Stay in the know with updates to Ixekizumab for Bullous Pemphigoid Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.